Market Place
Sourcing Support
Tagworks Pharma Initiates Phase 0/1 Clinical Trial For TGW211
15 Oct 2025 //
PR NEWSWIRE
Tagworks Starts Third Dose Level in TGW101 Ph 1 Trial for Tumors
09 Sep 2025 //
PR NEWSWIRE
Tagworks Gets FDA IND OK, Starts Ph 1 for TGW101
22 Apr 2025 //
PR NEWSWIRE
Tagworks Pharmaceuticals Names Ken Mills CEO
01 Oct 2024 //
PR NEWSWIRE
Tagworks Appoints Ken Mills as CEO
01 Oct 2024 //
CONTRACT PHARMA
Tagworks Pharma Announces $65 M in Series A Financing
22 Jun 2023 //
PR NEWSWIRE
Tagworks Announces $65 Million in Series A Financing
21 Jun 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.